A member of the Ras oncogene family, RAP1A, mediates antileishmanial activity of monastrol

Journal of Antimicrobial Chemotherapy

Volumn 68, Issue 5, 2013, Pages 1071-1080

  Kaur, Jaspreet ^a   Dutta, Sujoy ^b   Chang, Kwang Poo ^b   Singh, Neeloo ^a  

^a CENTRAL DRUG RESEARCH INSTITUTE   (India)

^b ROSALIND FRANKLIN UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

Author keywords

Antileishmanial agents; Chemotherapy; Drug targets; Microarrays; Signal transduction

Indexed keywords

ANTINEOPLASTIC AGENT; MONASTROL; RAL PROTEIN;

APOPTOSIS; ARTICLE; CANCER CELL; CELL CYCLE G1 PHASE; GENE; GROWTH INHIBITION; IC 50; INTRACELLULAR LEISHMANIA; INTRACELLULAR LEISHMANIA INFECTION; LEISHMANIA; LEISHMANIASIS; MITOSIS INHIBITION; NONHUMAN; PROTEIN PRENYLATION;

ANTIPROTOZOAL AGENTS; CELL CYCLE CHECKPOINTS; GENE EXPRESSION PROFILING; HUMANS; LEISHMANIA; MICROARRAY ANALYSIS; PRENYLATION; PROTEIN PROCESSING, POST-TRANSLATIONAL; PYRIMIDINES; RAP1 GTP-BINDING PROTEINS; THIONES;

EID: 84877107105     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dks507     Document Type: Article

References (36)

1. Leishmaniasis. http://www.dndi.org/diseases/vl.html (26 November 2012, date last accessed).
2. Croft SL, Seifert K, Yardley V. Current scenario of drug development for leishmaniasis. Indian J Med Res 2006; 123: 399-410.
3. Kaur J, Sundar S, Singh N. Molecular docking, structure-activity relationship and biologic evaluation of the anticancer drug monastrol as pteridine reductase inhibitor in Leishmania donovani clinical isolate. J Antimicrob Chemother 2010; 65: 1742-8.
4. Mayer TU, Kapoor TM, Haggarty SJ et al. Small molecule inhibitor of mitotic spindle bipolarity identified in a phenotype-based screen. Science 1999; 286: 971-4.
5. Haque SA, Hasaka TP, Ari D et al. Monastrol, a prototype anti-cancer drug that inhibits a mitotic kinesin, induces rapid bursts of axonal outgrowth from cultured postmitotic neurons. Cell Motil Cytoskeleton 2004; 58: 10-6.
6. Dutta S, Ongarora BG, Li H et al. Intracellular targeting specificity of novel phthalocyanines assessed in a host-parasite model for developing potential photodynamic medicine. PLoS ONE 2011; 6: e20786.
7. Liu X, Chang KP. Identification by extrachromosomal amplification and overexpression of z-crystallin/NADPH-oxidoreductase homologue constitutively expressed in Leishmania spp. Mol Biochem Parasitol 1994; 66: 201-10.
8. Braz RFS, Nascimento ET, Martins DRA et al. The sensitivity and specificity of Leishmania chagasi recombinant K39 antigen in the diagnosis of American visceral leishmaniasis and in differentiating active from subclinical infection. Am J Trop Med Hyg 2002; 67: 344-8.
9. Sahasrabuddhe AA, Bajpai VK, Gupta CM. A novel form of actin in Leishmania: molecular characterisation, subcellular localisation and association with subpellicular microtubules. Mol Biochem Parasitol 2004; 134: 105-14.
10. Kapoor P, Sahasrabuddhe AA, Kumar A et al. An unconventional form of actin in protozoan hemoflagellate, Leishmania. J Biol Chem 2008; 283: 22760-73.
11. Tammana TVS, Sahasrabuddhe AA, Mitra K et al. Actin-depolymerizing factor, ADF/cofilin, is essentially required in assembly of Leishmania flagellum. Mol Microbiol 2008; 70: 837-52.
12. Kumar P, Sundar S, Singh N. Degradation of pteridine reductase 1 (PTR1) enzyme during growth phase in the protozoan parasite Leishmania donovani. Exp Parasitol 2007; 116: 182-9.
13. Geryk-Hall M, Yang Y, Hughes DPM. Driven to death: inhibition of farnesylation increases ras activity in osteosarcoma and promotes growth arrest and cell death. Mol Cancer Ther 2010; 9: 1111-9.
14. Awasthi A, Samarakoon A, Chu H et al. Rap1b facilitates NK cell functions via IQGAP1-mediated signalosomes. J Exp Med 2010; 207: 1923-38.
15. Seabra MC. Membrane association and targeting of prenylated Ras-like GTPases. Cell Signal 1998; 10: 167-72.
16. Roelofs AJ, Thompson K, Gordon S et al. Molecular mechanisms of action of bisphosphonates: current status. Clin Cancer Res 2006; 12: 6222s-30s.
17. Lee CH, Della NG, Chew CE et al. Rin, a neuron-specific and calmodulin-binding small G-protein, and Rit define a novel subfamily of Ras proteins. J Neurosci 1996; 16: 6784-94.
18. Raaijmakers JH, Bos JL. Specificity in Ras and Rap signaling. J Biol Chem 2009; 284: 10995-9.
19. Journé F, Kheddoumi N, Chaboteaux C et al. Extracellular calcium increases bisphosphonate-induced growth inhibition of breast cancer cells. Breast Cancer Res 2008; 10: 1-11.
20. Mehta A, Shaha C. Apoptotic death in Leishmania donovani promastigotes in response to respiratory chain inhibition: complex II inhibition results in increased pentamidine cytotoxicity. J Biol Chem 2004; 279: 11798-813.
21. Efuet E, Keyomarsi K. Farnesyl and geranylgeranyl transferase inhibitors induce G1 arrest by targeting the proteasome. Cancer Res 2006; 66: 1040-51.
22. Casey PJ. Biochemistry of protein prenylation. J Lipid Res 1992; 33: 1731-40.
23. Grellier P, Depoix D, Schrevel J et al. Discovery of new targets for antimalarial chemotherapy. Parasite 2008; 15: 219-25.
24. Rodriguez NE, Chang HK, Wilson ME. Novel program of macrophage gene expression induced by phagocytosis of Leishmania chagasi. Infect Immun 2004; 72: 2111-22.
25. Chakrabarti D, Azam T, DelVecchio C et al. Protein prenyl transferase activities of Plasmodium falciparum. Mol Biochem Parasitol 1998; 94: 175-84.
26. Body JJ. Breast cancer: bisphosphonate therapy for metastatic bone disease. Clin Cancer Res 2006; 12: 6258s-63s.
27. Rogers MJ, Crockett JC, Coxon FP et al. Biochemical and molecular mechanisms of action of bisphosphonates. Bone 2011; 49: 34-41.
28. Obando D, Widmer F, Wright LC et al. Synthesis, antifungal and antimicrobial activity of alkylphospholipids. Bioorg Med Chem 2007; 15: 5158-65.
29. Raymond F, Boisvert S, Roy G et al. Genome sequencing of the lizard parasite Leishmania tarentolae reveals loss of genes associated to the intracellular stage of human pathogenic species. Nucleic Acids Res 2012; 40: 1131-47.
30. Bender A, Pringle JR. Multicopy suppression of the cdc24 budding defect in yeast by CDC42 and three newly identified genes including the ras-related gene RSR1. Proc Natl Acad Sci 1989; 86: 9976-80.
31. Seastone DJ, Zhang L, Buczynski G et al. The small Mr Ras-like GTPase Rap1 and the phospholipase C pathway act to regulate phagocytosis in Dictyostelium discoideum. Mol Biol Cell 1999; 10: 393-404.
32. Ong HB, Sienkiewicz N, Wyllie S et al. Dissecting the metabolic roles of pteridine reductase 1 in Trypanosoma brucei and Leishmania major. J Biol Chem 2011; 286: 10429-38.
33. Chin GM, Herbst R. Induction of apoptosis by monastrol, an inhibitor of the mitotic kinesin Eg5, is independent of the spindle checkpoint. Mol Cancer Ther 2006; 5: 2580-91.
34. Jackson JH, Cochrane CG, Bourne JR et al. Farnesol modification of Kirsten-ras exon 4B protein is essential for transformation. Proc Natl Acad Sci USA 1990; 87: 3042-6.
35. Vogt A, Qian Y, McGuire TF et al. Protein geranylgeranylation, not farnesylation, is required for the G1 to S phase transition in mouse fibroblasts. Oncogene 1996; 13: 1991-9.
36. Vogt A, Sun J, Qian Y et al. The geranylgeranyltransferase-I inhibitor GGTI-298 arrests human tumor cells in G0/G1 and induces p21 (WAF1/CIP1/SDI1) in a p53-independent manner. J BiolChem 1997; 272: 27224-9.